Fineline Cube

Follow:
14428 Articles
NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy
Policy / Regulatory

NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy

Junshi Biosciences' Toripalimab Gains TGA Approval for Nasopharyngeal Carcinoma
CompanyDrug

Junshi Biosciences’ Toripalimab Gains TGA Approval for Nasopharyngeal Carcinoma

Inscinstech Secures C-Series Financing for Biopharma Expansion
Company

Inscinstech Secures C-Series Financing for Biopharma Expansion

Raytone Bio Completes Angel Round to Advance iSus® Platform
Company

Raytone Bio Completes Angel Round to Advance iSus® Platform

Aosaikang's Limertinib Approved for EGFR T790M-Mutated NSCLC
CompanyDrug

Aosaikang’s Limertinib Approved for EGFR T790M-Mutated NSCLC

Johnson & Johnson Submits NDA for TAR-200 in High-Risk Bladder Cancer
CompanyDrug

Johnson & Johnson Submits NDA for TAR-200 in High-Risk Bladder Cancer

Eli Lilly's Omvoh Approved by FDA for Crohn's Disease Treatment
CompanyDrug

Eli Lilly’s Omvoh Approved by FDA for Crohn’s Disease Treatment

IVIEW Therapeutics Secures Series A++ Funding for Ophthalmology Pipeline
CompanyDeals

IVIEW Therapeutics Secures Series A++ Funding for Ophthalmology Pipeline

Boehringer Ingelheim's Iclepertin Fails to Meet Phase III Study Endpoints
CompanyDrug

Boehringer Ingelheim’s Iclepertin Fails to Meet Phase III Study Endpoints

Telix Pharmaceuticals' TLX591-CDx Approved in Europe via Decentralized Procedure
CompanyDrug

Telix Pharmaceuticals’ TLX591-CDx Approved in Europe via Decentralized Procedure

NMPA Implements Regulatory Reforms for Drug and Medical Device Industries
Policy / Regulatory

NMPA Implements Regulatory Reforms for Drug and Medical Device Industries

Daiichi Sankyo Acquires Gatipotuzumab IP Rights for $132.5M
CompanyDeals

Daiichi Sankyo Acquires Gatipotuzumab IP Rights for $132.5M